HHS Advisory Opinion on Contract Pharmacies FINALLY!!!
December 30, 2020
HHS released an advisory opinion regarding certain manufacturer’s refusal to sell 340B drugs through a contract pharmacy. See documents attached. “The Office of the General
HHS released an advisory opinion regarding certain manufacturer’s refusal to sell 340B drugs through a contract pharmacy. See documents attached. “The Office of the General
https://www.pharmacytimes.com/news/landmark-supreme-court-ruling-state-regulation-of-pbm-reimbursement-rates This will help protect the recent trend by the PBM’s to lower the reimbursement for a 340B drug dispensed vs a non-340B drug. Already
Health Resources and Services Administration (HRSA) released the procedures and requirements for the 340B Program’s Administrative Dispute Resolution (“ADR”). This has been 10 years in
Hospitals Sue HHS over Pharma 340B Pricing for contract Pharmacy attack.See complaint attached.